Related Experiment Video
Updated: Oct 1, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
PET/CT: Radiation Therapy Planning in Head and Neck Cancer
1Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2280 Inwood Drive, Dallas, TX 75390, USA.
Abstract:
Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) has an integral role in modern radiotherapy planning for most patients with head and neck malignancies. Fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) should guide standard target delineation and has emerging roles in dose and volume modification for escalation/de-escalation and adaptive radiotherapy. This article discusses the integration of PET/CT into radiotherapy planning.

